Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Johnson & Johnson

TRADE

NYSE: JNJHealthcare / Drug Manufacturers - Major / USA
138.91-0.55-0.39%Vol 2 705 8201Y Perf -1.42%
Oct 18th, 2018 12:41
BID138.91 ASK138.93
Open139.20 Previous Close139.46
Pre-Market138.99 After-Trading139.46
 -0.47 -0.34%  - -%
Target Price
146.46 
Analyst Rating
Moderate Buy 2.07
Potencial %
5.63 
Finscreener Ranking
     33.49
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
+     34.85
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
     37.81
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
★★     42.13
Market Cap (mil)372 682 
Earnings Rating
Price Range Ratio 52wk %
68.32 
Earnings Date

Today's Price Range

137.71139.40

52wk Range

118.62148.32

5 Year PE Ratio Range

16.9024.90

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Neutral
Performance
1 Month
-0.77%
3 Months
9.12%
6 Months
9.19%
1 Year
-1.42%
3 Years
44.04%
5 Years
62.18%

Quotes

Name / TickerPriceChg.Chg.%
JNJ138.91-0.5500-0.39
AAPL217.99-3.2000-1.45
GOOG1 093.72-21.9700-1.97
MSFT109.37-1.3400-1.21
XOM82.230.73000.90
WFC53.45-1.0100-1.85
FB155.62-3.8000-2.38
GE12.400.21001.72
JPM108.87-0.9600-0.87
 
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.20
Current Ratio 1.70
Long Term Debt to Total Capital 0.32
Total Debt to Equity 0.51
Interest Coverage 18.50
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin65.70
EBIT Margin23.30
EBITDA Margin32.10
Pre-tax Profit Margin25.50
Profit Margin-3.66
ValuationValueIndustryS&P 500US Markets
PE Ratio 257.40
PB Ratio 5.71
PS Ratios 5.88
Price to Cash Flow 16.60
Price to Free Cash Flow 66.90
Cash Flow Per Share 8.06
Price to Tangible Book-20.51
Book Value per Share23.44
Enterprise Value (in ths.)373 085 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)18.41
ROE last 12 Months 2.07
Return on Assets (5Y Avg) 8.28
ROA last 12 Months 0.90
Return on Capital (5Y Avg) 14.33
ROC last 12 Months 1.41
Return on invested Capital Q 4.24
Return on invested Capital Y1.39
Assets Turnover0.40
Receivables Turnover4.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)61 034 000
Revenue per Share 22.75
Revenue Growth 3 Years -0.95
Revenue Growth 5 Years -0.58
DividendsValueIndustryS&P 500US Markets
Dividend Yield 2.69
Dividend Rate 3.60
Dividend Growth 3 Years5.14
Dividend Growth 5 Years5.99

Earnings HistoryEstimateReportedSurprise %
Q03 20182.032.050.99
Q02 20182.062.101.94
Q01 20182.012.062.49
Q04 20171.721.741.16
Q03 20171.801.905.56
Q02 20171.791.832.23
Q01 20171.771.833.39
Q04 20161.561.581.28
Earnings Per EndEstimateRevision %Trend
9/2018 QR2.030.00-
12/2018 QR1.93-1.53Negative
12/2018 FY8.140.12Positive
12/2019 FY8.62-0.35Negative
Next Report Date16th Oct 2018
Estimated EPS Next Report2.03
Estimates Count8
EPS Growth Next 5 Years %7.70
Volume Overview
Volume2 705 820
Shares Outstanding (in ths.)2 682 900
Trades Count14 503
Dollar Volume323 747 081
Avg. Volume6 947 442
Avg. Weekly Volume6 722 333
Avg. Monthly Volume6 804 903
Avg. Quarterly Volume6 111 269

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

72%28%

Bearish Bullish

49%51%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (40.00 %)
7 (43.75 %)
7 (38.89 %)
Moderate Buy
2 (13.33 %)
2 (12.50 %)
2 (11.11 %)
Hold
7 (46.67 %)
7 (43.75 %)
7 (38.89 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
2 (11.11 %)
RatingModerate Buy
2.07
Moderate Buy
2.00
Moderate Buy
2.33

There are no comments yet.

News

x